Restless Legs Syndrome and the Gut Connection
The Restless Legs Syndrome (RLS) Foundation is hosting a free webinar Wednesday on "SIBO, Diet and RLS" with Leonard Weinstock, MD.
Category: Restless Legs Syndrome
Restless Legs Syndrome
LatestRestless Legs Syndrome
Latest
Noctrix Health Enrolls First Patient in Wearable RLS Therapy Clinical Trial
The RESTFUL Study is a two-phase, randomized, double-blind, sham-controlled clinical trial to evaluate the company's wearable NTX100 Neuromodulation System in patients with moderate-severe primary RLS.
Restless Legs Syndrome
LatestRestless Legs Syndrome Research Reaches Its Stride
The discovery of how restless legs syndrome patients lack iron availability in a part of their brains is due to the work of Christopher Earley, MBBCh, PhD, and his research collaborators, whose initial work launched a decades-long investigation into the pathophysiology of RLS.
A Neurologist Remembers His Friend and Research Collaborator Richard P. Allen, PhD
Restless legs syndrome pioneer Richard Allen died on Dec 9, 2020, with his family by his side.
Read MoreObit: Richard P. Allen, PhD
Dignity Memorial: Restless legs syndrome pioneer Riichard Putnam Allen, 82, of Arnold, Maryland, passed away on December 9, 2020 at home, with his family by his side.
Read MoreWearable RLS Therapy Developer Completes $17M Million Series B Financing
Noctrix Health is developing a neuromodulation-based approach to treat RLS and has obtained a Breakthrough Device Designation from the FDA.
Read MoreRace & Ethnicity May Not Play Role in RLS During Pregnancy
Penn State investigators found differences between different racial and ethnic groups and the prevalence of restless legs syndrome during pregnancy, but they do not believe that race was the cause of the differences.
Read More
Reducing RLS Augmentation: Scientist Identifies a New Pathway to Maintain Restless Legs Syndrome Treatment Efficacy
A patent proposes a new treatment method that targets the increased D1 receptor levels in RLS patients experiencing augmentation.
Read MoreCannabis for Restless Leg Syndrome
Psychology Today examines how the blend of chemicals in the cannabis plant acts within the brains of people with restless leg syndrome.
Read More
Are Dopamine Agonists Doing More Harm Than Good for Restless Legs Syndrome Patients?
A new study finds about 20% of restless legs syndrome patients are prescribed doses above the recommended maximum.
Read More
Why I Evaluate My Neuropathy Patients for Restless Legs Syndrome
New research finds that small fiber neuropathy is linked with RLS and has a significant impact on quality of life.
Read More
Wearable Restless Legs Syndrome Therapy Granted FDA Breakthrough Device Designation
Noctrix Health aims to treat RLS symptoms with its wearable neuromodulation platform that targets specific peripheral nerve fibers in a manner that is comfortable to wear to sleep.
Read MoreStudy Establishes Correlation Between Restless Legs Syndrome and Superficial Venous Insufficiency
A retrospective study finds that symptoms of restless leg syndrome are 34.5% more prevalent in patients with superficial venous insufficiency, reports Venous News.
Read MoreStudy Identifies Risk Factors for Restless Legs Syndrome
Researchers have identified several risk factors for restless legs syndrome in patients on hemodialysis, a condition found to be highly prevalent in this patient population. In addition, the effects of restless leg syndrome on...
Read More
FDA Warns of Serious Breathing Problems with Gabapentinoids When Used with CNS Depressants or in Patients with Lung Problems
An FDA-approved drug for restless legs syndrome is included. The US Food and Drug Administration...
Read More
What New Research Suggests About Psychiatric Adverse Events and Popular Restless Legs Syndrome Drugs
A decades-old assumption that dopamine agonists are linked to impulse control and other mental...
Read More
FDA Responds to Citizen Petitions Requesting Black Box Warnings on Dopamine Agonists for Restless Legs Syndrome
In a 39-page letter dated October 21, 2019, the US Food and Drug Administration (FDA) responded to...
Read More
AASM Issues Position Statement on Chronic Opioid Therapy and Sleep
Patients and medical providers should be aware that chronic opioid use can interfere with sleep by...
Read More